Belimumab
Trade Name:
Benlysta
Manufacturer/Distributor:
GlaxoSmithKline
gsk.ca 1-800-387-7374
Classification:
Immunosuppressant
ATC Class:
L04AA26 - Belimumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2011/07/06
Date Marketed in Canada (yyyy/mm/dd):
2011/10/01
Presentation:
Injection: 120 mg/5mL. DIN: 02370050
Injection: 400 mg/5mL. DIN: 02370069
Comments:
Treatment of systemic lupus erythematosus in adults.
| Posted | Updated |
|---|---|
| 2011-12-05 14:46 | 2011-12-05 14:50 |
